US Food and Drug Administration approves 'Dupixent' for treatment of bronchitis

The US Food and Drug Administration (FDA) has approved French pharmaceutical company Sanofi's Dupixent, an anti-bronchitis drug for smokers.According to the Washington Post, the drug's approval followed EU and Chinese approval, and was based on two studies that showed that Dupixent significantly reduc...